Clinical Trial Update: Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty [Phase 3]

View source ↗

Summary

Phase 3 trial update for leuprolide acetate injectable suspension in central precocious puberty has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Precocious Puberty
• Precocious Puberty

Drugs mentioned

• Leuprolide acetate injectable suspension (leuprolide acetate)

Snippet

Sponsor: Tolmar Inc. | Conditions: Precocious Puberty, Central | Phase 3 | Status: COMPLETED | Results posted: 2020-05-20